|
1
|
Mamelak AN and Jacoby DB: Targeted
delivery of antitumoral therapy to Glioma and other malignancies
with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv.
4:175–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Radner H, El-Shabrawi Y, Eibl RH, Brüstle
O, Kenner L, Kleihues P and Wiestler OD: Tumor induction by ras and
myc oncogenes in fetal and neonatal brain: Modulating effects of
developmental stage and retroviral dose. Acta Neuropathol.
86:456–465. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong ET and Brem S: Taming glioblastoma:
Targeting angiogenesis. J Clin Oncol. 25:4705–4706. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang B, Chaichana K, Veeravagu A, Chang
SD, Black KL and Patil CG: Biopsy versus resection for the
management of low-grade gliomas. The Cochrane Database of
Systematic Reviews. 4:CD0093192017.PubMed/NCBI
|
|
5
|
Stewart L and Burdett S; Glioma
Meta-analysis Trialists Group (GMT), : Chemotherapy for high-grade
glioma. Cochrane Database Syst Rev. CD0039132012.
|
|
6
|
Davis FG and McCarthy BJ: Current
epidemiological trends and surveillance issues in brain tumors.
Expert Rev Anticancer Ther. 1:395–401. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Snyder GL and Greenberg S: Effect of
anaesthetic technique and other perioperative factors on cancer
recurrence. Br J Anaesth. 105:106–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kvolik S, Glavas-Obrovac L, Bares V and
Karner I: Effects of inhalation anesthetics halothane, sevoflurane,
and isoflurane on human cell lines. Life Sci. 77:2369–2383. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kvolik S, Dobrosevic B, Marczi S, Prlic L
and Glavas-Obrovac L: Different apoptosis ratios and gene
expressions in two human cell lines after sevoflurane anaesthesia.
Acta Anaesthesiol Scand. 53:1192–1199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang H, Gu M, Yang C, Wang H, Wen X and
Zhou Q: Sevoflurane inhibits invasion and migration of lung cancer
cells by inactivating the p38 MAPK signaling pathway. J Anesth.
26:381–392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goto G, Hori Y, Ishikawa M, Tanaka S and
Sakamoto A: Changes in the gene expression levels of microRNAs in
the rat hippocampus by sevoflurane and propofol anesthesia. Mol Med
Rep. 9:1715–1722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ciafre SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng Q, Wu X, Li F, Ning B, Lu X, Zhang Y,
Pan Y and Guan W: miR-27b inhibits gastric cancer metastasis by
targeting NR2F2. Protein Cell. 8:114–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Xu T, Cao YW and Ding XQ: Antitumor
effect of miR-27b-3p on lung cancer cells via targeting Fzd7. Eur
Rev Med Pharmacol Sci. 21:4113–4123. 2017.PubMed/NCBI
|
|
19
|
Luo Y, Yu SY, Chen JJ, Qin J, Qiu YE,
Zhong M and Chen M: MiR-27b directly targets Rab3D to inhibit the
malignant phenotype in colorectal cancer. Oncotarget. 9:3830–3841.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan FH, Pandian V, Ramraj S, Aravindan S,
Herman TS and Aravindan N: Reorganization of metastamiRs in the
evolution of metastatic aggressive neuroblastoma cells. BMC
Genomics. 16:5012015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yi W, Li D, Guo Y, Zhang Y, Huang B and Li
X: Sevoflurane inhibits the migration and invasion of glioma cells
by upregulating microRNA-637. Int J Mol Med. 38:1857–1863. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin J, Teo S, Lam DH, Jeyaseelan K and
Wang S: MicroRNA-10b pleiotropically regulates invasion,
angiogenicity and apoptosis of tumor cells resembling mesenchymal
subtype of glioblastoma multiforme. Cell Death Dis. 3:e3982012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song L, Huang Q, Chen K, Liu L, Lin C, Dai
T, Yu C, Wu Z and Li J: miR-218 inhibits the invasive ability of
glioma cells by direct downregulation of IKK-β. Biochem Biophys Res
Commun. 402:135–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan YC, Mei PJ, Chen C, Miao FA, Zhang H
and Li ZL: MiR-29c inhibits glioma cell proliferation, migration,
invasion and angiogenesis. J Neurooncol. 115:179–188. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Zhang B, Jin Y, Wu Q and Cao L:
MiR-27b targets PI3K p110α to inhibit proliferation and migration
in colorectal cancer stem cell. Am J Transl Res. 11:5988–5997.
2019.PubMed/NCBI
|
|
27
|
Sun W, Zhang L, Yan R, Yang Y and Meng X:
LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration
of non-small cell lung cancer cells by targeting the
miR-27b-3p/GSPT1 axis. Onco Targets Ther. 12:3945–3954. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu C, Liang S, Xiao S, Lin Q, Chen X, Wu
Y and Fu J: MicroRNA-27b inhibits Spry2 expression and promotes
cell invasion in glioma U251 cells. Oncol Lett. 9:1393–1397. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Li H, Han L, Zhang K, Wang G, Wang
Y, Liu Y, Zheng Y, Jiang T, Pu P, et al: Expression and function of
miR-27b in human glioma. Oncol Rep. 26:1617–1621. 2011.PubMed/NCBI
|
|
30
|
Wen MM: Getting miRNA therapeutics into
the target cells for neurodegenerative diseases: A mini-review.
Front Mol Neurosci. 9:1292016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dhup S, Dadhich RK, Porporato PE and
Sonveaux P: Multiple biological activities of lactic acid in
cancer: Influences on tumor growth, angiogenesis and metastasis.
Curr Pharm Des. 18:1319–1330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yancopoulos GD: Clinical application of
therapies targeting VEGF. Cell. 143:13–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stetler-Stevenson WG and Seo DW: TIMP-2:
An endogenous inhibitor of angiogenesis. Trends M ol Med.
11:97–103. 2005. View Article : Google Scholar
|
|
34
|
Tapia A, Salamonsen LA, Manuelpillai U and
Dimitriadis E: Leukemia inhibitory factor promotes human first
trimester extravillous trophoblast adhesion to extracellular matrix
and secretion of tissue inhibitor of metalloproteinases-1 and −2.
Hum Reprod. 23:1724–1732. 2008. View Article : Google Scholar : PubMed/NCBI
|
